Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 421 participants.
Also called NCT01066715
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 421 participants
- Sponsor
- XOMA (US) LLC
- Registry
-
NCT01066715
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01066715. Randomized; quadruple masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- XOMA 052
- Intervention (Drug)
- Placebo
- Lead sponsor
- XOMA (US) LLC
Record details
- Record id
cardio:ct-nct01066715- Content hash
e18eb00f913472d01252aa561b09f4ad645a4adbc2280c47518fe5615fc5e458